Position in ESPR
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$45,886
+$45,886 QoQ
Shares Held
14,521
+16.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 40 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $4,102,863 across 16 Drug Manufacturers - Specialty & Generic names. ESPR ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,603 | $650,866 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
15,724 | $545,151 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
3,992 | $442,872 | |
| 4 | ALKS |
Alkermes plc.
|
8,340 | $436,974 | |
| 5 | LQDA |
Liquidia Corp
|
4,705 | $375,129 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
6,049 | $285,936 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
11,358 | $196,606 | |
| 8 | VTRS |
Viatris Inc
|
12,123 | $192,513 |
All Filings in ESPR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,886 | 14,521 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | — | 12,496 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | — | 28,943 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 12,142 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | — | 12,312 | Shares | Sole | 2025-07-23 | |
| No filing history on record for this holder in this stock. | ||||||